We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

BioTek Readers Receive BellBrook Certifications

Read time: Less than a minute

BioTek's complete line of multi-mode microplate readers have now earned Transcreener HTS Assay certifications from BellBrook Labs. Performance of BioTek readers including the Synergy™ Neo2 and Cytation™ 5 have been confirmed as meeting validation requirements across BellBrook's supported Fluorescence Intensity, Fluorescence Polarization and TR-FRET detection modes.

Synergy Neo2 is designed for speed and ultra high performance, incorporating BioTek's patented Hybrid Technology™, with its independent optical paths that ensure uncompromised performance in all detection modes. Continuously variable bandwidth quadruple monochromators, sensitive high transmission filter-based optics, and up to 4 PMTs provide ultra-fast measurements with excellent results.

Cytation 5 is a modular, upgradable multi-mode reader that combines automated digital microscopy and conventional microplate detection. Cytation 5 also incorporates BioTek’s patented Hybrid Technology with both filter- and monochromator-based detection; the microscopy module provides up to 60x magnification in fluorescence, brightfield, color brightfield and phase contrast.

Available laser autofocus and image-based autofocus ensures fast and accurate image acquisition with minimized phototoxicity across a broad application range.

Other BioTek readers earning the Transcreener certifications include Synergy™ H1, Synergy™ 2, and Synergy™ HTX.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.